MYC and pancreatic neoplasm: Our group found that homeodomain‐interacting protein kinase (HIPK) inhibits the ERK‐cMyc axis, reducing cMyc protein levels and downregulating the expression of the cMyc‐targeted glycolytic gene, thus restraining the proliferation of pancreatic cancer.54